The US Department of Health and Human Services made public a final HIPAA Privacy Rule on November 16, 2026, changing patient access to health records and information sharing for care coordination. The filing also explains how clinical-trial apps differ from patient-controlled health apps, making the text relevant to university medical centres, research sponsors and teams developing digital research tools.
Final rule is filed ahead of November 19 publication
The Federal Register public-inspection entry records the filing at 4:15pm on November 16 and schedules publication for November 19. The document is identified as a final rule from HHS’s Office for Civil Rights, with regulation identifier RIN 0945-AA00 and document number 2026-23429.
The 363-page final text modifies the Privacy Rule’s standards for individual access, care coordination, notices and several categories of disclosure. It sets effectiveness at 60 days after Federal Register publication and the general compliance deadline at 240 days after publication. The displayed text leaves the corresponding calendar dates as publication-dependent placeholders.
Patient access requests get a shorter initial response period
HHS’s summary says covered entities will have no more than 15 calendar days to respond to an access request, compared with the current 30 days. It retains an extension of up to 30 calendar days. The rule also addresses the form and format of access, identity verification and the fees that can be charged for providing copies.
Covered entities will need to post estimated fee schedules on their websites for copies obtained through the right of access and through an individual’s valid authorisation. The final text specifies circumstances in which electronic information must be provided to the individual without a charge. These changes make access workflows and public-facing information part of the implementation task for covered academic health organisations.
The rule also removes the requirement for a provider with a direct treatment relationship to obtain written acknowledgement that an individual received its Notice of Privacy Practices. It changes the notice’s content requirements to explain privacy rights and how to exercise them. HHS describes these changes as measures to improve transparency while reducing administrative burdens.
The clinical-trial app distinction matters for research
The final text adds a definition of a personal health application focused on information managed, shared and controlled by or primarily for the individual. HHS distinguishes that arrangement from apps controlled primarily for a covered entity or another organisation. The distinction concerns how the information is managed and for whom the app operates.
HHS gives a clinical-trial example: an entity may supply a participant with an app that collects health information, but manage that information primarily for the organisation conducting the trial. The agency explains that such an app falls outside the personal-health-app definition. It also discusses apps controlled by medical product companies conducting research and the separate, limited right to direct electronic health-record copies to another person.
For university sponsors and developers, the practical implication is to describe the app’s purpose and data control accurately when designing access arrangements. A participant-facing interface alone does not determine its regulatory category. CASRAI’s background on HIPAA in clinical research explains the wider research context for reviewing those data flows.
Care coordination and communications provisions also change
The final rule clarifies individual-level care coordination and case management within the definition of health care operations. It also clarifies disclosures to social service agencies, community organisations and similar providers of health-related services when they support an individual’s care coordination or case management.
Other provisions expressly permit certain disclosures to telecommunications relay service assistants and revise the treatment of relay providers in the business-associate definition. HHS also expands a permission concerning Armed Forces personnel to cover all Uniformed Services, including the Public Health Service and NOAA commissioned corps. Academic health organisations reviewing the package will need to identify which provisions apply to their own services and relationships.
Earlier independent analysis anticipated policy changes
In a July 8 analysis, Davis Wright Tremaine lawyers Adam Greene, Rebecca Williams and Apurva Dharia identified the coordinated-care Privacy Rule as a nearer-term item than the separate Security Rule overhaul. They highlighted possible changes to notices and access rights and warned that regulatory-agenda dates were projections. Their analysis provides background to the final filing now available.
In an October 13 assessment, HIPAA Journal editor Steve Alder likewise discussed the expected coordinated-care rule and the separate security-rule timetable. Both analyses predate the November 16 filing. The final document supplies the adopted provisions and publication-linked implementation periods that covered institutions can now assess.
What research offices and university medical centres should prepare
Research offices supporting covered university health services can coordinate with privacy officers, records teams and digital research developers on three tasks: reviewing access-response procedures, identifying notice and fee-schedule changes, and classifying apps by their actual data-management arrangements. These are implementation priorities drawn from the final text’s provisions and clinical-trial example.
Contract owners should also review the rule’s transition provision for qualifying business associate agreements. HHS provides additional transition time for some agreements beyond the general compliance period. The relevant contract terms and eligibility conditions therefore need attention alongside the organisation’s broader HITECH and HIPAA compliance framework.
Publication starts the implementation calendar
The next dated milestone is the scheduled November 19 Federal Register publication. The rule ties both its 60-day effective period and 240-day general compliance period to publication. Covered institutions should use the final published notice to establish their calendar dates and account separately for the business-associate transition provisions.
For research teams handling identifiable health information, the filing provides specific text to review with institutional HIPAA specialists. Its clinical-trial app example is particularly relevant when investigators combine participant-facing software, sponsor-controlled data collection and requests for electronic health records.
Sources
- HHS Office for Civil Rights: final rule 2026-23429, public-inspection text, November 16, 2026, checked 2026-11-16.
- Federal Register: filing details and November 19 scheduled publication, checked 2026-11-16.
- Davis Wright Tremaine: HHS Updates Rulemaking Timeframes, July 8, 2026, checked 2026-11-16.
- HIPAA Journal: State of HIPAA – 2027 Predictions, October 13, 2026, checked 2026-11-16.







